This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Rakuten Medical, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: C Daniel De Magalhaes Filho: Innovator in Photoimmunotherapy
Introduction
C Daniel De Magalhaes Filho is a notable inventor based in La Jolla, California. He has made significant contributions to the field of photoimmunotherapy, particularly through his innovative methods and applications. His work focuses on improving therapeutic outcomes for patients with tumors and cancers.
Latest Patents
C Daniel De Magalhaes Filho holds 1 patent for his invention titled "Methods for photoimmunotherapy and related biomarkers." This patent provides methods involving the use of biomarkers in relation to photoimmunotherapy. The methods include the activation of a phthalocyanine dye conjugated to a targeting molecule that binds to proteins on tumor cells. The invention also encompasses combination therapies that include photoimmunotherapy and additional therapeutic agents, such as immune modulating agents. These methods aim to identify subjects suitable for photoimmunotherapy and assess their likelihood of response to treatment. The advantages of these methods include improved efficacy and the potential for personalized medicine.
Career Highlights
C Daniel De Magalhaes Filho is currently associated with Rakuten Medical, Inc., where he continues to advance his research and innovations in the field of medical therapies. His work is pivotal in developing new treatment regimens that can be tailored to individual patient needs.
Collaborations
He collaborates with esteemed colleagues, including Miguel Garcia-Guzman and Roger Heim, to further enhance the impact of his research and innovations in the medical field.
Conclusion
C Daniel De Magalhaes Filho's contributions to photoimmunotherapy represent a significant advancement in cancer treatment methodologies. His innovative approaches and dedication to personalized medicine are paving the way for improved therapeutic outcomes for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
